{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T21:46:14Z","timestamp":1785793574429,"version":"3.56.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-24141-w","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T08:33:15Z","timestamp":1755160395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Global burden and trends of multiple myeloma attributable to high body mass index: a comprehensive analysis of the global burden of disease 2021 study with projections to 2040"],"prefix":"10.1186","volume":"25","author":[{"given":"Yue","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"issue":"18","key":"24141_CR1","doi-asserted-by":"publisher","first-page":"e70224","DOI":"10.1002\/cam4.70224","volume":"13","author":"L Huang","year":"2024","unstructured":"Huang L, He J. Trend analysis of hematological tumors in adolescents and young adults from 1990 to 2019 and predictive trends from 2020 to 2044: A global burden of disease study. Cancer Med. 2024;13(18):e70224.","journal-title":"Cancer Med"},{"key":"24141_CR2","doi-asserted-by":"publisher","first-page":"1527198","DOI":"10.3389\/fpubh.2025.1527198","volume":"13","author":"L Zhuge","year":"2025","unstructured":"Zhuge L, Lin X, Fan Z, et al. Global, regional and National epidemiological trends of multiple myeloma from 1990 to 2021: a systematic analysis of the global burden of disease study 2021. Front Public Health. 2025;13:1527198.","journal-title":"Front Public Health"},{"key":"24141_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217440","volume":"611","author":"X Dou","year":"2025","unstructured":"Dou X, Duan G, Zhong Y, et al. The burden of multiple myeloma in China: trends from 1990 to 2021 and forecasts for 2050. Cancer Lett. 2025;611: 217440.","journal-title":"Cancer Lett"},{"issue":"1","key":"24141_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-025-01675-5","volume":"18","author":"H Zheng","year":"2025","unstructured":"Zheng H, Xian H, Zhang W, et al. BCMA-targeted therapies for multiple myeloma: latest updates from 2024 ASH annual meeting. J Hematol Oncol. 2025;18(1): 23.","journal-title":"J Hematol Oncol"},{"key":"24141_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2025.101256","volume":"70","author":"T Yue","year":"2025","unstructured":"Yue T, Sun Y, Dai Y, Jin F. Mechanisms for resistance to BCMA-targeted immunotherapies in multiple myeloma. Blood Rev. 2025;70: 101256.","journal-title":"Blood Rev"},{"issue":"1","key":"24141_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11912-024-01623-5","volume":"27","author":"N Mehra","year":"2025","unstructured":"Mehra N, Sundaram S, Shah P, Rao A. Epigenetic role of long Non-coding RNAs in multiple myeloma. Curr Oncol Rep. 2025;27(1):37\u201344.","journal-title":"Curr Oncol Rep"},{"issue":"5","key":"24141_CR7","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/s41416-023-02571-w","volume":"130","author":"Y Kataria","year":"2024","unstructured":"Kataria Y, Niharika Pillalamarri B, Zirpoli G, Szalat R, Palmer JR, Bertrand KA. Body size and risk of multiple myeloma in the black women\u2019s health study. Br J Cancer. 2024;130(5):830\u20135.","journal-title":"Br J Cancer"},{"issue":"2","key":"24141_CR8","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41416-024-02723-6","volume":"131","author":"KD Arnold","year":"2024","unstructured":"Arnold KD, Ong KL, Ravi G, et al. Anthropometric traits and risk of multiple myeloma: differences by race, sex and diagnostic clinical features. Br J Cancer. 2024;131(2):312\u201324.","journal-title":"Br J Cancer"},{"issue":"11","key":"24141_CR9","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.ejca.2011.01.020","volume":"47","author":"A Wallin","year":"2011","unstructured":"Wallin A, Larsson SC. Body mass index and risk of multiple myeloma: a meta-analysis of prospective studies. Eur J Cancer. 2011;47(11):1606\u201315.","journal-title":"Eur J Cancer"},{"issue":"10","key":"24141_CR10","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1634\/theoncologist.2010-0206","volume":"15","author":"MA Lichtman","year":"2010","unstructured":"Lichtman MA. Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myeloma. Oncologist. 2010;15(10):1083\u2013101.","journal-title":"Oncologist"},{"issue":"11","key":"24141_CR11","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1002\/ijc.22968","volume":"121","author":"SC Larsson","year":"2007","unstructured":"Larsson SC, Wolk A. Body mass index and risk of multiple myeloma: a meta-analysis. Int J Cancer. 2007;121(11):2512\u20136.","journal-title":"Int J Cancer"},{"issue":"1","key":"24141_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s13679-025-00644-w","volume":"14","author":"L Manna","year":"2025","unstructured":"Manna L, Gelsomino L, Martino EA, et al. Unraveling obesity and multiple myeloma: insights from epidemiology and molecular mechanisms. Curr Obes Rep. 2025;14(1):52.","journal-title":"Curr Obes Rep"},{"key":"24141_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.918330","volume":"9","author":"X Zhi","year":"2022","unstructured":"Zhi X, Kuang XH, Liu K, Li J. The global burden and temporal trend of cancer attributable to high body mass index: estimates from the global burden of disease study 2019. Front Nutr. 2022;9: 918330.","journal-title":"Front Nutr"},{"issue":"1","key":"24141_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11033-024-10174-8","volume":"52","author":"M Stanislawowski","year":"2024","unstructured":"Stanislawowski M. Effect of adipose tissue on the development of multiple myeloma. Mol Biol Rep. 2024;52(1):74.","journal-title":"Mol Biol Rep"},{"issue":"11","key":"24141_CR15","doi-asserted-by":"publisher","first-page":"e0287917","DOI":"10.1371\/journal.pone.0287917","volume":"18","author":"A Poopak","year":"2023","unstructured":"Poopak A, Saeedi Moghaddam S, Esfahani Z, et al. National and subnational burden of leukemia and its risk factors, 1990\u20132019: results from the global burden of disease study 2019. PLoS ONE. 2023;18(11):e0287917.","journal-title":"PLoS ONE"},{"issue":"10481","key":"24141_CR16","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0140-6736(25)00355-1","volume":"405","author":"GBDAB Collaborators","year":"2025","unstructured":"Collaborators GBDAB. Global, regional, and National prevalence of adult overweight and obesity, 1990\u20132021, with forecasts to 2050: a forecasting study for the global burden of disease study 2021. Lancet. 2025;405(10481):813\u201338.","journal-title":"Lancet"},{"issue":"1","key":"24141_CR17","first-page":"35","volume":"15","author":"C Samanic","year":"2004","unstructured":"Samanic C, Gridley G, Chow WH, Lubin J, Hoover RN, Fraumeni JF. Jr. Obesity and cancer risk among white and black united States veterans. Cancer Causes Control. 2004;15(1):35\u201343.","journal-title":"Cancer Causes Control"},{"issue":"7630","key":"24141_CR18","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1136\/bmj.39367.495995.AE","volume":"335","author":"GK Reeves","year":"2007","unstructured":"Reeves GK, Pirie K, Beral V, et al. Cancer incidence and mortality in relation to body mass index in the million women study: cohort study. BMJ. 2007;335(7630):1134.","journal-title":"BMJ"},{"issue":"7","key":"24141_CR19","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.ejca.2008.11.004","volume":"45","author":"KC Soderberg","year":"2009","unstructured":"Soderberg KC, Kaprio J, Verkasalo PK, et al. Overweight, obesity and risk of haematological malignancies: a cohort study of Swedish and Finnish twins. Eur J Cancer. 2009;45(7):1232\u20138.","journal-title":"Eur J Cancer"},{"issue":"3","key":"24141_CR20","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/ijc.24803","volume":"126","author":"AG Renehan","year":"2010","unstructured":"Renehan AG, Soerjomataram I, Tyson M, et al. Incident cancer burden attributable to excess body mass index in 30 European countries. Int J Cancer. 2010;126(3):692\u2013702.","journal-title":"Int J Cancer"},{"issue":"1","key":"24141_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/aje\/kwj353","volume":"165","author":"A Engeland","year":"2007","unstructured":"Engeland A, Tretli S, Hansen S, Bjorge T. Height and body mass index and risk of lymphohematopoietic malignancies in two million Norwegian men and women. Am J Epidemiol. 2007;165(1):44\u201352.","journal-title":"Am J Epidemiol"},{"issue":"17","key":"24141_CR22","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJMoa021423","volume":"348","author":"EE Calle","year":"2003","unstructured":"Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults. N Engl J Med. 2003;348(17):1625\u201338.","journal-title":"N Engl J Med"},{"key":"24141_CR23","doi-asserted-by":"crossref","unstructured":"Sonderman JS, Bethea TN, Kitahara CM et al. Multiple myeloma mortality in relation to obesity among African Americans. J Natl Cancer Inst 2016;108(10):djw120.","DOI":"10.1093\/jnci\/djw120"},{"issue":"4","key":"24141_CR24","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/annonc\/mdz045","volume":"30","author":"L Abar","year":"2019","unstructured":"Abar L, Sobiecki JG, Cariolou M, et al. Body size and obesity during adulthood, and risk of lympho-haematopoietic cancers: an update of the WCRF-AICR systematic review of published prospective studies. Ann Oncol. 2019;30(4):528\u201341.","journal-title":"Ann Oncol"},{"issue":"9","key":"24141_CR25","doi-asserted-by":"publisher","first-page":"e0308463","DOI":"10.1371\/journal.pone.0308463","volume":"19","author":"S Mahmud","year":"2024","unstructured":"Mahmud S, Hossain MF, Muyeed A, et al. Risk assessment and clinical implications of COVID-19 in multiple myeloma patients: A systematic review and meta-analysis. PLoS ONE. 2024;19(9):e0308463.","journal-title":"PLoS ONE"},{"issue":"10440","key":"24141_CR26","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","volume":"403","author":"Collaborators GBDRF","year":"2024","unstructured":"Collaborators GBDRF. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403(10440):2162\u2013203.","journal-title":"Lancet"},{"issue":"10440","key":"24141_CR27","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"GBD Diseases","year":"2024","unstructured":"Diseases GBD, Injuries C. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403(10440):2133\u201361.","journal-title":"Lancet"},{"issue":"10258","key":"24141_CR28","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"Collaborators GBDRF","year":"2020","unstructured":"Collaborators GBDRF. Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1223\u201349.","journal-title":"Lancet"},{"issue":"10440","key":"24141_CR29","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","volume":"403","author":"Collaborators GBDCoD","year":"2024","unstructured":"Collaborators GBDCoD. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease study 2021. Lancet. 2024;403(10440):2100\u201332.","journal-title":"Lancet"},{"issue":"3","key":"24141_CR30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1530\/EJE-21-0703","volume":"186","author":"NY Loh","year":"2022","unstructured":"Loh NY, Humphreys E, Karpe F, Tomlinson JW, Noordam R, Christodoulides C. Sex hormones, adiposity, and metabolic traits in men and women: a Mendelian randomisation study. Eur J Endocrinol. 2022;186(3):407\u201316.","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"24141_CR31","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1194\/jlr.R086975","volume":"60","author":"AP Frank","year":"2019","unstructured":"Frank AP, de Souza Santos R, Palmer BF, Clegg DJ. Determinants of body fat distribution in humans may provide insight about obesity-related health risks. J Lipid Res. 2019;60(10):1710\u20139.","journal-title":"J Lipid Res"},{"issue":"10113","key":"24141_CR32","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1016\/S0140-6736(17)32129-3","volume":"390","author":"NCDRF Collaboration","year":"2017","unstructured":"Collaboration NCDRF. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627\u201342.","journal-title":"Lancet"},{"key":"24141_CR33","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-3-319-42542-9_13","volume":"208","author":"AG Renehan","year":"2016","unstructured":"Renehan AG, Soerjomataram I. Obesity as an avoidable cause of cancer (Attributable Risks). Recent Results Cancer Res. 2016;208:243\u201356.","journal-title":"Recent Results Cancer Res"},{"issue":"7","key":"24141_CR34","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41416-018-0010-4","volume":"118","author":"CR Marinac","year":"2018","unstructured":"Marinac CR, Birmann BM, Lee IM, et al. Body mass index throughout adulthood, physical activity, and risk of multiple myeloma: a prospective analysis in three large cohorts. Br J Cancer. 2018;118(7):1013\u20139.","journal-title":"Br J Cancer"},{"issue":"7","key":"24141_CR35","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s40273-014-0243-x","volume":"33","author":"A Hruby","year":"2015","unstructured":"Hruby A, Hu FB. The epidemiology of obesity: A big picture. PharmacoEconomics. 2015;33(7):673\u201389.","journal-title":"PharmacoEconomics"},{"issue":"2","key":"24141_CR36","first-page":"88","volume":"69","author":"H Sung","year":"2019","unstructured":"Sung H, Siegel RL, Torre LA, et al. Global patterns in excess body weight and the associated cancer burden. CA Cancer J Clin. 2019;69(2):88\u2013112.","journal-title":"CA Cancer J Clin"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-24141-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-24141-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-24141-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T22:22:59Z","timestamp":1757456579000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-24141-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24141"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-24141-w","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2774"}}